Efficacy and Safety Study of GED-0507-34-Levo for Treatment of UC
Status:
Terminated
Trial end date:
2017-07-31
Target enrollment:
Participant gender:
Summary
This is a Phase 2, multicenter, randomized, double-blind, placebo-controlled, parallel-group
study to evaluate the efficacy and safety of 2 doses of GED-0507-34-Levo in subjects with
active, mild-to-moderate UC.